Elicio Therapeutics, Inc. (NASDAQ:ELTX) IPO

Elicio Therapeutics, Inc.

IPO

Went public as Angion Biomedica Corp. Priced at US$16.00 a share on Feb 4, 2021.

Price
US$16.00 a share
Shares offered
5,000,000 shares of common stock
Offering size
US$80 million
Underwriters' option
Up to 750,000 more shares
Listing
ANGN on the Nasdaq Global Select Market
Underwriters
Cowen, Stifel, H.C. Wainwright & Co., Oppenheimer & Co. · In the order on the cover

Steps

StepWhen
Draft sent to the SEC in confidenceFeb 14, 2020
Filed publiclyJan 15, 2021
Amended twiceNewest Feb 4, 2021
Shares registered with an exchangeFeb 2, 2021
Declared effective by the SECFeb 4, 2021
Final prospectus, with the priceFeb 5, 2021

From the cover of the final prospectus (424B4) filed Feb 5, 2021